Author: Xiaotian Tan; Cory Lin; Jie Zhang; Maung Kyaw Khaing Oo; Xudong Fan
Title: Rapid and quantitative detection of COVID-19 markers in micro-liter sized samples Document date: 2020_4_22
ID: 0tdfvlqd_45
Snippet: We have demonstrated a portable chemiluminescent microfluidic ELISA system that is able to conduct sensitive detection and quantification of SARS-CoV-2-related biomarkers in only 15-20 minutes using micro-liter sized sample volumes. The LLOD of 2 ng/mL for IgG in serum was achieved using the humanized chimeric antibodies as the model system. We also successfully characterized different antibodies and identified an antibody candidate, D006, which .....
Document: We have demonstrated a portable chemiluminescent microfluidic ELISA system that is able to conduct sensitive detection and quantification of SARS-CoV-2-related biomarkers in only 15-20 minutes using micro-liter sized sample volumes. The LLOD of 2 ng/mL for IgG in serum was achieved using the humanized chimeric antibodies as the model system. We also successfully characterized different antibodies and identified an antibody candidate, D006, which can be used as the calibration antibody for quantitative evaluation of anti-SARS-CoV-2 S1 IgG. This approach can also be extended to evaluation of therapeutic convalescent plasma. Furthermore, we demonstrated sensitive detection of SARS-CoV-2 S1 protein (antigen) with the LLOD of 0.4 ng/mL. Finally, we showed that our technology can be used as an alternative approach for rapid (8.5 minutes) screening and validation of monoclonal anti-S1 antibodies. Our method requires only tens of nanograms, which is several orders of magnitude smaller than used traditional label-free methods (such as BLI and SPR), and will be useful in screening and selection of high affinity therapeutic neutralization antibodies and research-use antibodies 23, 27-29 .
Search related documents:
Co phrase search for related documents- alternative approach and different antibody: 1
- alternative approach and magnitude order: 1, 2
- alternative approach and model system: 1, 2, 3
- anti s1 antibody and chimeric antibody: 1
- anti s1 antibody and monoclonal anti s1 antibody: 1, 2
- anti SARS and calibration antibody: 1
- anti SARS and different antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- anti SARS and ELISA system: 1, 2, 3, 4
- anti SARS and magnitude order: 1, 2
- anti SARS and model system: 1, 2, 3, 4
- antibody candidate and calibration antibody: 1
- calibration antibody and different antibody: 1
- chimeric antibody and different antibody: 1, 2
- chimeric antibody and monoclonal anti s1 antibody: 1
- different antibody and ELISA system: 1
- different antibody and model system: 1
- ELISA system and model system: 1
- magnitude order and model system: 1
Co phrase search for related documents, hyperlinks ordered by date